Mindcure’s Kelsey Ramsden: Despite Market Slump, ‘Everything Is Moving In The Right Direction’ For Psychedelics Jan 25, 2022
MINDCURE Announces Certification of HIPAA Compliance, Bringing iSTRYM Closer to Commercial Deployment in the Second… Dec 16, 2021
Ibogaine Addiction Treatments & MDMA Assisted-Psychotherapy: MINDCURE & The State Of Psychedelic Therapeutics… Nov 23, 2021
CEOs Kelsey Ramsden and Anthony Tennyson Talk Psychedelic Partnerships: “Further, Faster, Together” Nov 16, 2021
